Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
40,762,262
-
Total 13F shares
-
18,401,048
-
Share change
-
+14,808,412
-
Total reported value
-
$1,256,450,046
-
Price per share
-
$69.02
-
Number of holders
-
99
-
Value change
-
+$1,018,297,205
-
Number of buys
-
92
Institutional Holders of Pulmonx Corp - COM (LUNG) as of Q4 2020
As of 31 Dec 2020,
Pulmonx Corp - COM (LUNG) was held by
99 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,401,048 shares.
The largest 10 holders included
KPCB XIII Associates, LLC, RTW INVESTMENTS, LP, GILDER GAGNON HOWE & CO LLC, VANGUARD GROUP INC, BlackRock Inc., ABG Innovation Capital Partners III GP Ltd, ABG-WTT Global Life Science Capital Partners GP Ltd, PRIMECAP MANAGEMENT CO/CA/, Capital World Investors, and FMR LLC.
This page lists
99
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.